Cempra Inc (CEMP)

4.55
0.30 7.10
NASDAQ : Health Care
Prev Close 4.25
Open 4.25
Day Low/High 4.25 / 4.72
52 Wk Low/High 14.03 / 46.99
Volume 1.03M
Avg Volume 849.40K
Exchange NASDAQ
Shares Outstanding 52.50M
Market Cap 215.26M
EPS -2.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Cempra Reports First Quarter 2017 Financial Results And Provides Corporate Update

Management to host webcast and conference call today at 8:45 a.m. ET

Cempra To Report First Quarter 2017 Financial Results

—Management to host webcast and conference call on Friday, April 28, 2017 at 8:45 a.m. ET—

Biotech Premarket Movers: Cempra, Tesaro, Editas

Biotech Premarket Movers: Cempra, Tesaro, Editas

Cempra, Tesaro and Editas Medicine were among the biotech stock movers in premarket trading on Tuesday.

Cempra Withdraws Solithromycin Marketing Authorization Application In Europe

—Company plans to resubmit MAA with additional data, in alignment with FDA strategy—

Biotech Premarket Movers: Cempra, Blueprint Medicines, Aralez

Biotech Premarket Movers: Cempra, Blueprint Medicines, Aralez

Cempra, Blueprint Medicines and  Aralez Pharmaceuticals were among the biotech stock movers in premarket trading on Monday.

Cempra To Present At 29th Annual ROTH Conference

—Presentation time at Cowen and Company 37th Annual Health Care Conference on Monday, March 6 changed to 2:40 p.m. ET—

Biotech Premarket Movers: Cempra, Novavax, Ionis

Biotech Premarket Movers: Cempra, Novavax, Ionis

Cempra, Novavax and Ionis Pharmaceuticals were among the biotech stock movers in premarket trading on Tuesday.

Biotech Premarket Movers: BioCryst, Sangamo, Cempra

Biotech Premarket Movers: BioCryst, Sangamo, Cempra

BioCryst Pharmaceuticals, Sangamo Therapeutics and Cempra were among the biotech stock movers in premarket trading on Monday.

4 Biotech Stocks on the Move

4 Biotech Stocks on the Move

These four biotech stocks have been moving on some interesting news and clinical results.

Biotech Movers: Cempra Flys High On Phase Three Results

Biotech Movers: Cempra Flys High On Phase Three Results

Other movers include Incyte, Achillion and Inovio.

Cempra To Report Fourth Quarter And Full Year 2016 Financial Results

Management to host webcast and conference call on Tuesday, February 28, 2017 at 8:45 a.m. EST

Acorda, Amgen and Regeneron Lead Premarket Biotech Movers

Acorda, Amgen and Regeneron Lead Premarket Biotech Movers

Acorda was soaring ahead of the market open, thanks to positive late-stage clinical trial results for levodopa.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Cempra, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 3, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Cempra, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 3, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Cempra, Inc.

GPM Reminds Investors Of The January 3 Deadline In The Class Action Lawsuit Against Cempra, Inc.

GPM Reminds Investors Of The January 3 Deadline In The Class Action Lawsuit Against Cempra, Inc.

Glancy Prongay & Murray LLP ("GPM") reminds investors of the January 3, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Cempra, Inc.

Wall Street Falls Again as Financial Stocks Lead the Decline

Wall Street Falls Again as Financial Stocks Lead the Decline

Stocks slumped for the second consecutive day as markets adjust to mixed economic data and the financial sector led the decline.

Wall Street Slumps As Financial Stocks Lead the Decline

Wall Street Slumps As Financial Stocks Lead the Decline

Stocks are volatile at midday Thursday and are turning mostly negative as markets adjust to mixed economic data and as the financial sector slumps.

Midday Report: Volatile Stocks Turn Negative; Cempra Plummets, Sears Soars

Midday Report: Volatile Stocks Turn Negative; Cempra Plummets, Sears Soars

Stocks were volatile Thursday as markets adjust to mixed economic data. Sears shares are seeing a boost while Cempra's stock plummets.

Stocks Volatile After Trade Deficit Data; Oil Inventories Rise

Stocks Volatile After Trade Deficit Data; Oil Inventories Rise

Stocks were mixed Thursday morning as markets adjusted to losses on Wednesday and investors received mixed economic data.

Cempra Receives Complete Response Letter From FDA For Solithromycin NDAs

Cempra Receives Complete Response Letter From FDA For Solithromycin NDAs

Management to host webcast and conference call today at 9:00 a.m. ET